BioPharma Credit PLC (BPCR) — Working Capital to Net Assets Ratio
BioPharma Credit PLC (BPCR) has a Working Capital to Net Assets ratio of 4.5% as of June 2025. Working capital of $51.48 Million (current assets of $58.98 Million minus current liabilities of $7.49 Million) is measured against net assets of $1.15 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see BioPharma Credit PLC total assets.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
BioPharma Credit PLC Working Capital to Net Assets (2017–2024)
This chart shows how BioPharma Credit PLC's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 4.5%, reflecting working capital of $51.48 Million against net assets of $1.15 Billion USD. Check BPCR cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Annual Working Capital to Net Assets for BioPharma Credit PLC (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for BioPharma Credit PLC from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Explore investment intensity of BioPharma Credit PLC to see how much of total assets are deployed in long-term investments.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 1.7% | $19.53 Million | $1.18 Billion | $37.42 Million | $17.88 Million | ▼ -8.8 pp |
| 2023 | 10.4% | $139.50 Million | $1.34 Billion | $155.37 Million | $15.87 Million | ▲ +1.9 pp |
| 2022 | 8.5% | $114.06 Million | $1.34 Billion | $140.37 Million | $26.30 Million | ▲ +1.3 pp |
| 2021 | 7.2% | $98.38 Million | $1.36 Billion | $104.72 Million | $6.34 Million | ▼ -6.1 pp |
| 2020 | 13.3% | $184.08 Million | $1.38 Billion | $193.48 Million | $9.39 Million | ▼ -7.2 pp |
| 2019 | 20.5% | $288.34 Million | $1.40 Billion | $312.84 Million | $24.50 Million | ▼ -7.0 pp |
| 2018 | 27.6% | $380.55 Million | $1.38 Billion | $386.01 Million | $5.46 Million | ▼ -10.7 pp |
| 2017 | 38.3% | $352.94 Million | $922.57 Million | $355.86 Million | $2.92 Million | — |